When blood and adipose tissue are collected from a client within the next 30 days, it will mark the first time in the U.S. that adult stem cells have been harvested from both sources for future medical use. LifeStem's Stem Cell Microbank(TM) Service is expected to be offered in other spas in other states soon.
LifeStem(TM) is a wholly-owned subsidiary of CalbaTech. The unique process it developed allows for the collection of adult stem cells in micro quantities to be cryopreserved for future transplantation into the same client for medical purposes. LifeStem(TM) also trained the staff on selling techniques.
"Four people were given contracts for immediate service with others expected to follow soon after," said James DeOlden, CalbaTech CEO. "It makes sense to bank adult stem cells while the person is healthy for possible future medical use, with possible therapies ranging from heart disease to diabetes and other medical issues that are currently difficult to treat."
About CalbaTech
CalbaTech, Inc. (OTC Bulletin Board: CLBE - News) is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, as well as providing services in the collection, processing and storage of adult stem cells.
Note: Certain statements in this news release may contain "forward- looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to being in a large and growing market, exhibiting rapid growth characteristics, and having a growth strategy, are forward looking statements. These forward looking statements are only predictions and are subject to certain risks, uncertainties and assumptions. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or assumptions in this press release include the risk that we will not be able to grow our revenues and market share, the risk that our prices do not remain competitive and the risk that we will not achieve profitability. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission, including our most recent Report on Form 10-KSB, and Reports on Form 10-QSB and Form 8-K. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
Contact: Paul Knopick E & E Communications 1-949-707-5365
